Ampliphi Bio was pleased to participate in Cell & Gene Therapy Boston, one of the leading events for the life sciences industry.

During the event, we focused on our capabilities in pDNA and mRNA, which are essential for developing new cell and gene therapies. Our team also highlighted our GMP manufacturing services, ensuring products are made to the highest quality and meet regulatory standards.

At the conference, Ampliphi Bio showcased how we support partners with:

• Reliable pDNA production for use in mRNA, viral vectors, and other advanced therapies.
• Scalable mRNA manufacturing for vaccines and therapeutics.
• GMP-compliant facilities and processes that meet global standards.
• Flexible partnerships to help projects move smoothly from research to clinical and commercial stages.

Our participation underscored our commitment to helping innovators bring safe and effective therapies to patients faster. The event was a valuable opportunity to connect with new partners and share how Ampliphi Bio supports the growing cell and gene therapy community.